ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,510 | -3.7% | 642 | 0.0% | 0.04% | -4.3% |
| Q2 2023 | $81,508 | -1.7% | 642 | 0.0% | 0.05% | -11.3% |
| Q1 2023 | $82,921 | -1.6% | 642 | 0.0% | 0.05% | -3.6% |
| Q4 2022 | $84,288 | +12.4% | 642 | 0.0% | 0.06% | -1.8% |
| Q3 2022 | $75,000 | -1.3% | 642 | 0.0% | 0.06% | +1.8% |
| Q2 2022 | $76,000 | -9.5% | 642 | 0.0% | 0.06% | +3.8% |
| Q1 2022 | $84,000 | -14.3% | 642 | 0.0% | 0.05% | -10.2% |
| Q4 2021 | $98,000 | -5.8% | 642 | 0.0% | 0.06% | -13.2% |
| Q3 2021 | $104,000 | -1.0% | 642 | 0.0% | 0.07% | -1.4% |
| Q2 2021 | $105,000 | +8.2% | 642 | 0.0% | 0.07% | -2.8% |
| Q1 2021 | $97,000 | 0.0% | 642 | 0.0% | 0.07% | -1.4% |
| Q4 2020 | $97,000 | +11.5% | 642 | 0.0% | 0.07% | 0.0% |
| Q3 2020 | $87,000 | 0.0% | 642 | 0.0% | 0.07% | -7.7% |
| Q2 2020 | $87,000 | +26.1% | 642 | 0.0% | 0.08% | +21.9% |
| Q1 2020 | $69,000 | -10.4% | 642 | 0.0% | 0.06% | -9.9% |
| Q4 2019 | $77,000 | – | 642 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |